Skip to main content

DEUTSCHE BANK AG\

Bank

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in XERS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,193,187
+$579,718 QoQ
Shares Held
529,443
-15.0% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 238 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. XERS ranks #18 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,193,187 529,443
2026-03-31 $3,613,469 623,012
2025-12-31 $7,383,646 940,592
2025-09-30 $12,760,629 1,567,645
2025-06-30 $3,441,448 736,927
2025-03-31 $4,152,674 756,407
2024-12-31 $432,563 127,600
2024-09-30 $226,665 79,532
2024-06-30 $124,427 55,301
2024-03-31 $151,479 68,543
2023-12-31 $155,285 66,079
2023-09-30 $126,629 68,081
2023-06-30 $151,640 57,878
2023-03-31 $144,833 88,855
2022-12-31 $77,969 58,624
2022-09-30 $90,075 57,741
2022-06-30 $102,532 66,580